Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Other Working Capital Changes (2016 - 2026)

Corvus Pharmaceuticals' Other Working Capital Changes history spans 12 years, with the latest figure at $865000.0 for Q1 2026.

  • Quarterly Other Working Capital Changes rose 174.06% to $865000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Mar 2026, up 475.26% year-over-year, with the annual reading at -$941000.0 for FY2025, 273.3% down from the prior year.
  • Other Working Capital Changes came in at $865000.0 for Q1 2026, up from $204000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.1 million in Q2 2025 to a low of -$1.2 million in Q1 2025.
  • The 5-year median for Other Working Capital Changes is $204000.0 (2025), against an average of $21647.1.
  • Year-over-year, Other Working Capital Changes tumbled 343.18% in 2023 and then skyrocketed 691.67% in 2024.
  • Corvus Pharmaceuticals' Other Working Capital Changes stood at -$884000.0 in 2022, then skyrocketed by 105.43% to $48000.0 in 2023, then surged by 691.67% to $380000.0 in 2024, then crashed by 46.32% to $204000.0 in 2025, then surged by 324.02% to $865000.0 in 2026.
  • Per Business Quant, the three most recent readings for CRVS's Other Working Capital Changes are $865000.0 (Q1 2026), $204000.0 (Q4 2025), and -$1.1 million (Q3 2025).